Dario Neri

49PUBLICATIONS
133CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersGlycoconjugates
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (49)

|May 11, 2026
A Bispecific Anti-Fluorescein × Anti-CD3 T-cell Engager in Combination with Fluoresceinated Adaptors Enables Lysis of AML Cells.

|Apr 21, 2026
Targeted TNF Potentiates the Activity of Bispecific T-cell Engagers in Solid Tumors by Turning Cold Tumors Hot.

|Mar 30, 2026
Enhancement of CD117-Targeted Bispecific T-cell Engagement by CD33-Targeted Bispecific T-cell Costimulation in Acute Myeloid Leukemia.

Mara Hofstetter, Laura Volta, Christian Koch

|Mar 17, 2026
A bispecific anti-fluorescein x anti-CD3 T-cell engager in combination with fluoresceinated adaptors enables lysis of AML cells.

Laura G Volta, Celeste Gobbi, Christian Koch

|Jan 15, 2026
Exploring the 89Zr/177Lu Theranostic Pairing with an Extracellular Matrix-Targeted Radiopharmaceutical against Triple-Negative Breast Cancer.

Justin S Hachey, Tara D Viray, Sebastian E Carrasco

|Sep 30, 2025
Immunocompetent Mouse Models of Cancer Reveal the Superiority of Cellular Targets over Stromal Targets for the Development of Anticancer Bispecific Antibodies.

Stefanie K Pfister, Frauke Seehusen, Francesco Prisco

Pageof 9

Frequent Collaborators

13 joint publications

Samuele Cazzamalli

12 joint publications

Jörg Scheuermann

10 joint publications

Christian Pellegrino

9 joint publications

Markus G Manz